Global Inhaled Nitric Oxide NO Delivery Systems Market by Type (General Type, Intelligent Type), By Application (Infant, Adult) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

The Global Inhaled Nitric Oxide NO Delivery Systems Market size was valued at $2.8 billion in 2018 and is projected to grow at a CAGR of 5.3% from 2021 to 2028. The growth in this market will be supported by the rising prevalence of chronic respiratory diseases such as asthma and COPD, increasing awareness about the benefits of inhaled nitric oxide therapy among patients with acute or chronic respiratory conditions, improving product innovation in terms of cost-effective delivery systems for inhalation drugs that can provide accurate doses adjusted on body weight or disease severity and growing demand from emerging economies.

Inhaled Nitric Oxide Delivery Systems are the medical devices that provide inhaled nitric oxide therapy to patients with acute or chronic respiratory conditions. They come in two types: general type and intelligent type. These devices are used to treat respiratory conditions which include pulmonary hypertension, chronic obstructive pulmonary disease, and other lung diseases. These devices can also be used in cardiology procedures for the treatment of coronary artery disease when combined with a balloon catheter or stent placement.

On the basis of Types, the market is segmented into General Type and Intelligent Type. General type devices are further segmented into nasal types, oral types, and others (nasal hoods). On the other hand. intelligent type is primarily split on the basis of inhaler device, nebulizer device, and system-inhalers.

General Type:

The general type is an inhaler that delivers nitric oxide gas directly into the lungs without using electronics while intelligent types provide inhaled nitric oxide therapy through electronic controls by monitoring patient's breathing patterns and adjusting Nitric Oxide concentration accordingly. General type devices are used to deliver a continuous flow of nitric oxide gas from an external tank. They typically provide stable levels of oxygen and humidity which is required for the therapy treatment.

Intelligent Type:

Intelligent type delivery systems allow precise adjustment in terms of dose based on weight or disease severity. This is done by incorporating a microprocessor that can control the dosage delivered through inhalation. The intelligent type also has built-in sensors that monitor a patient's breathing patterns with instantaneous feedback information to adjust if necessary before delivering nitric oxide gas into the lungs.

On the basis of Applications, the market is segmented into Infant Applications & Adult applications.

Infant:

The use of inhaled nitric oxide NO delivery systems in infant applications is expected to witness considerable growth during the forecast period from 2021 to 2028. This can be attributed primarily due to the increasing prevalence of respiratory tract infections and other related diseases, which are substantially worsening with time. As a result, physicians prescribe health care professionals such as neonatologists or pediatricians for the treatment of newborns suffering from these ailments by administering prophylactic medications that act directly on the lungs (e.g., bronchodilators) or through indirect effects (e.g., steroids). To prevent infants from premature airway closure at birth-a condition known as persistent pulmonary hypertension syndrome-physicians often administer inhaled nitric oxide NO delivery system. A NO delivery system is a device, which delivers an aerosolized drug (e.g., nitric oxide) to the respiratory tract for therapeutic purposes.

Adult:

The global inhaled nitric oxide NO delivery systems market for adult application is expected to grow at a CAGR of over 27% from 2021 to 2028. This growth can be attributed to the use of inhaled nitric oxide NO delivery systems for managing respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary vasculitis disorders as well as bronchiectasis. In addition, it has been found that inhalers are easy and comfortable to use by patients compared with nebulizers or metered-dose inhalers.

On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. The North American region is expected to be the largest market for inhaled nitric oxide NO delivery systems in 2021. This growth can be attributed to factors like increasing awareness about this technology among physicians as well as a growing number of respiratory diseases afflicting adults such as COPD and asthma which are more prevalent in countries like America than in other regions.

Growth Factors For The Global Inhaled Nitric Oxide NO Delivery Systems Market:

• The growing popularity of OncoNOx® and other NO products in the treatment of asthma and COPD. More than 50% of patients with chronic obstructive pulmonary disease (COPD) will experience an exacerbation at some point during their lifetime.
• Proven performance as a bronchodilator, vasopressor, systemic anticoagulant agent, antioxidant, and ischemic preconditioning agent. Nitric oxide has been used extensively to treat respiratory disorders such as pulmonary artery hypertension or acute lung injury.
• Increasing awareness about NO therapy among physicians- Physicians have increased familiarity with nitric oxide over time because it can be administered in various forms according to patient needs.
• Low-cost devices captured a sizable share of the market due to their affordability and availability.

Up Market Research published a new report titled “Inhaled Nitric Oxide NO Delivery Systems Market research report which is segmented by Types (General Type, Intelligent Type), By Applications (Infant, Adult), By Players/Companies International Biomedical, Praxair (NoxBox), Getinge, SLE, VERO Biotech”. 

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Inhaled Nitric Oxide NO Delivery Systems Market Report Segments:

The market is segmented by Type General Type, Intelligent Type and By Application Infant, Adult.

Some of the companies that are profiled in this report are:

1. International Biomedical
2. Praxair (NoxBox)
3. Getinge
4. SLE
5. VERO Biotech

Inhaled Nitric Oxide NO Delivery Systems Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Inhaled Nitric Oxide NO Delivery Systems Market

Overview of the regional outlook of the Inhaled Nitric Oxide NO Delivery Systems Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Inhaled Nitric Oxide NO Delivery Systems Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Inhaled Nitric Oxide NO Delivery Systems Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.
6. By Type:

                1. General Type

                2. Intelligent Type

                1. Infant

                2. Adult

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Inhaled Nitric Oxide NO Delivery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Inhaled Nitric Oxide NO Delivery Systems Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.